Search by Drug Name or NDC
NDC 65197-0203-09 Emetrol Powder 460 mg/1 Details
Emetrol Powder 460 mg/1
Emetrol Powder is a ORAL POWDER, FOR SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by WellSpring Pharmaceutical Corporation. The primary component is TRISODIUM CITRATE DIHYDRATE.
Product Information
| NDC | 65197-0203 |
|---|---|
| Product ID | 65197-203_9d8d2ee7-9db7-4be7-8c73-511eb2e32459 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Emetrol Powder |
| Proprietary Name Suffix | Non-Drowsy |
| Non-Proprietary Name | Sodium Citrate Dihydrate |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | POWDER, FOR SOLUTION |
| Route | ORAL |
| Active Ingredient Strength | 460 |
| Active Ingredient Units | mg/1 |
| Substance Name | TRISODIUM CITRATE DIHYDRATE |
| Labeler Name | WellSpring Pharmaceutical Corporation |
| Pharmaceutical Class | Acidifying Activity [MoA], Anti-coagulant [EPC], Calcium Chelating Activity [MoA], Calculi Dissolution Agent [EPC], Decreased Coagulation Factor Activity [PE] |
| DEA Schedule | n/a |
| Marketing Category | UNAPPROVED DRUG OTHER |
| Application Number | n/a |
| Listing Certified Through | 2024-12-31 |
Package
NDC 65197-0203-09 (65197020309)
| NDC Package Code | 65197-203-09 |
|---|---|
| Billing NDC | 65197020309 |
| Package | 6 POWDER, FOR SOLUTION in 1 CARTON (65197-203-09) |
| Marketing Start Date | 2023-12-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |